Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Mercer International
MERC
$26.9M
| $15.2M | 0.02% |
1,223,637
-58,087
| -5% | -$784K |
|
|
TYPE
1052
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $15.2M | 0.02% |
677,958
+635,399
| +1,493% | +$15.3M |
|
|
RDUS
1053
DELISTED
Radius Recycling
RDUS
| $15.2M | 0.02% |
470,441
-215,448
| -31% | -$7.52M |
|
1054
Builders FirstSource
BLDR
$7.56B
| $15.2M | 0.02% |
+766,759
| New | +$16.2M |
|
|
SYNT
1055
DELISTED
Syntel Inc
SYNT
| $15.2M | 0.02% |
595,458
+216,499
| +57% | +$5.37M |
|
|
FISV
1056
Fiserv Inc
FISV
$28.2B
| $15.2M | 0.02% |
212,773
+177,067
| +496% | +$12.5M |
|
1057
Four Corners Property Trust
FCPT
$2.8B
| $15.2M | 0.02% |
656,736
+274,890
| +72% | +$6.33M |
|
|
KW
1058
DELISTED
Kennedy-Wilson Holdings
KW
| $15.2M | 0.02% |
870,893
-44,493
| -5% | -$763K |
|
|
AMED
1059
DELISTED
Amedisys
AMED
| $15.1M | 0.02% |
250,473
-797,950
| -76% | -$45.5M |
|
|
EPZM
1060
DELISTED
Epizyme, Inc
EPZM
| $15.1M | 0.02% |
851,508
-145,179
| -15% | -$2.45M |
|
1061
Lakeland Financial Corp
LKFN
$1.5B
| $15.1M | 0.02% |
326,463
+231,781
| +245% | +$11.1M |
|
|
CBAY
1062
DELISTED
Cymabay Therapeutics
CBAY
| $15.1M | 0.02% |
1,160,275
+1,094,594
| +1,667% | +$13.6M |
|
1063
Genuine Parts
GPC
$18.7B
| $15M | 0.02% |
167,503
+155,094
| +1,250% | +$15M |
|
|
CLSD
1064
DELISTED
Clearside Biomedical
CLSD
| $15M | 0.02% |
93,182
+91,487
| +5,397% | +$11.1M |
|
1065
Toll Brothers
TOL
$13.8B
| $15M | 0.02% |
346,445
-1,699,054
| -83% | -$79.8M |
|
1066
Idacorp
IDA
$8B
| $15M | 0.02% |
169,669
-154,450
| -48% | -$13M |
|
1067
Healthcare Services Group
HCSG
$1.56B
| $14.9M | 0.02% |
343,271
+324,509
| +1,730% | +$15.9M |
|
|
ARNA
1068
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $14.9M | 0.02% |
377,830
-420,959
| -53% | -$16.4M |
|
|
SVC
1069
Service Properties Trust
SVC
$1.04B
| $14.9M | 0.02% |
117,487
-68,648
| -37% | -$9.24M |
|
1070
Acadia Pharmaceuticals
ACAD
$5.11B
| $14.9M | 0.02% |
661,358
+574,577
| +662% | +$15.9M |
|
1071
American Water Works
AWK
$27.8B
| $14.9M | 0.02% |
180,887
-105,738
| -37% | -$8.63M |
|
1072
iQIYI
IQ
$975M
| $14.8M | 0.02% |
+954,961
| New | +$14.8M |
|
1073
Reliance Steel & Aluminium
RS
$19.5B
| $14.8M | 0.02% |
173,171
+129,658
| +298% | +$11.6M |
|
|
VER
1074
DELISTED
VEREIT, Inc.
VER
| $14.8M | 0.02% |
425,207
-321,605
| -43% | -$11.4M |
|
1075
Insight Enterprises
NSIT
$4.26B
| $14.8M | 0.02% |
423,288
+200,041
| +90% | +$7.23M |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.